Camilla Simpson
Director/Board Member at SPRUCE BIOSCIENCES, INC.
Net worth: - $ as of 2024-03-30
Camilla Simpson active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Director/Board Member | 2017-11-12 | - |
| Independent Dir/Board Member | 2017-11-12 | - | |
| GRI BIO, INC. | Director/Board Member | 2023-04-23 | - |
| Independent Dir/Board Member | 2023-04-23 | - | |
| Rare Strategic LLC | Founder | 2019-03-31 | - |
| President | 2019-03-31 | - | |
Dyve Biosciences, Inc.
 Dyve Biosciences, Inc. BiotechnologyHealth Technology Dyve Biosciences, Inc. operates as a research and development company. It focuses on biotech that creates novel therapeutics using proprietary science. The company was founded by Ryan Beal and Rajit Malhotra and is headquartered in Thousand Oaks, CA. | Director/Board Member | 2020-11-30 | - |
Aristea Therapeutics, Inc.
 Aristea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aristea Therapeutics, Inc. operates as a clinical-stage drug development company. It develops novel therapies to treat serious inflammatory diseases. The company was founded by James Morrison MacKay in 2018 and is headquartered in Poway, CA. | Director/Board Member | 2019-10-31 | - |
Zehna Therapeutics, Inc.
 Zehna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zehna Therapeutics, Inc. develops non-bactericidal inhibitors for cardiovascular and chronic kidney diseases. The company is based in Cleveland, OH. | Director/Board Member | - | - |
| Chief Executive Officer | 2021-03-31 | - |
Career history of Camilla Simpson
Former positions of Camilla Simpson
| Companies | Position | Start | End |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 2017-03-31 | 2019-03-31 |
| GRI BIOPAR | Director/Board Member | 2023-04-20 | - |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | General Counsel | - | - |
Training of Camilla Simpson
| University of London | Graduate Degree |
| Kingston University | Undergraduate Degree |
| National University of Ireland Galway | Undergraduate Degree |
Statistics
International
| United States | 9 |
| United Kingdom | 3 |
| Ireland | 2 |
Operational
| Director/Board Member | 6 |
| Undergraduate Degree | 2 |
| Independent Dir/Board Member | 2 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
Aristea Therapeutics, Inc.
Aristea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aristea Therapeutics, Inc. operates as a clinical-stage drug development company. It develops novel therapies to treat serious inflammatory diseases. The company was founded by James Morrison MacKay in 2018 and is headquartered in Poway, CA. | Health Technology |
Dyve Biosciences, Inc.
Dyve Biosciences, Inc. BiotechnologyHealth Technology Dyve Biosciences, Inc. operates as a research and development company. It focuses on biotech that creates novel therapeutics using proprietary science. The company was founded by Ryan Beal and Rajit Malhotra and is headquartered in Thousand Oaks, CA. | Health Technology |
| Rare Strategic LLC | |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA. | Health Technology |
Zehna Therapeutics, Inc.
Zehna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zehna Therapeutics, Inc. develops non-bactericidal inhibitors for cardiovascular and chronic kidney diseases. The company is based in Cleveland, OH. | Health Technology |
| GRI Bio, Inc. |
- Stock Market
- Insiders
- Camilla Simpson
- Experience
